VC  Elm Street Ventures

http://www.elmvc.com





     Office Locations:

33 Whitney Avenue
New Haven, CT 06510
Phone: 203-401-4201
Fax: 203-401-4235

 

Stages:

  • Early
  • Seed


 

Industries:

  • Energy & Clean Tech
  • Information Technology
  • Life Sciences & Healthcare
  • Medical Device
  • Software & Internet

  •  

    Description:

    Elm Street Ventures' principal strategy is to create and initially operate life sciences companies founded on intellectual property developed at Yale University and other research institutions in the region (from New York City through Southern New England). Elm Street Ventures helps scientists build significant technology companies from the seed and early stages. Its partners include successful serial entrepreneurs and experienced corporate managers, who may serve as the interim CEOs or operating chairmen of a number of the companies formed. While Elm Street Ventures expects to be co-founders of companies in some circumstances, the firm is also interested in hearing from entrepreneurs, scientists, and engineers who have already formed or plan to form new ventures in the life sciences. Elm Street Ventures' investments range from $500,000 to $1 million, and, if a company is tracking well, look to invest $2 to $2.5 million over multiple financing rounds. The firm will consider companies in the following industries: Life Sciences (including therapeutics, medical devices, diagnostics, research tools and services, materials, healthcare, and healthcare services); Clean technology, with an emphasis on green chemistry; and Information technology including mobile and social web.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or New York Database subscription.
    Chris McLeod Managing Partner
    David R. Whittaker MD Venture Partner
    Rebecca Velez Frey PharmD Venture Partner
    Rob Bettigole Managing Partner

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      08/12/2024


      Halda Therapeutics


      CT


      $126,000,000


      Series B Extension


     

    Portfolio companies include:


      Ancera


      Arvinas


      AxioMx
        web link


      Cybrexa Therapeutics
        web link


      Desmos


      Device42
        web link


      Halda Therapeutics
        web link


      Iconic Therapeutics


      Kolltan


      Ocean Sciences


      P2 Science


      Saphlux


      Scroll Motion


      ShareGrove


      SMOL


     

    Recent News: